For the Professional in Government, Industry and
Academia with an interest in Nuclear, Biological and Chemical Defense,
Disarmament and Verification; Chemical and Biological Terrorism; Emergency
and Disaster Medical Planning; Industrial Health and Safety; and Environmental
ASA 07-2, Issue No. 119, April 6, 2007
It is a real pleasure for ASA is to have Dr. Benjamin Garrett again featured within the ASA Newsletter. For so many years he was a prime contributor to the Newsletter and to our CBRN&T world knowledge base in this most convoluted of arenas. In this article Dr. Ben looks at Dr. Jan Medema's article in the last issue, ASA 07-1. And as Ben says "I hope my response will be met with others, because the ASA family is vast ... and well informed".
"The myth of dusty mustard" - A Response
Benjamin C. Garrett, Ph.D.
Senior Scientist for WMD
FBI Laboratory, Quantico, VA
Dr. Jan Medema makes a welcome contribution to our understanding of dusty agent with his article in ASA 07-1, "The myth of dusty agent." He challenges conventional wisdom with facts that help clarify the picture regarding the hazard of dusty agent, correctly noting the loss of toxic agent payload when using a carrier with an agent in a chemical munition. He provides a useful historical perspective by noting the earliest reference he has encountered to dusty mustard. Finally, the end note by the editor invites comments. Let me offer a modest bit of informaiton in the hopes it helps to clarify matters further.
The CBMTS Industry V "Fourth World Congress on CBR&T" begins 14 April 2007 in Dubrovnik, Croatia. We would like to provide our readers with a selected group of Abstracts based on scheduled presentations at this CBMTS.
CBMTS Industry V: A Presentation Overview
An important area being considered in-depth for this 14th meeting in the CBMTS series is Dual Use and Biosecurity, Biosafety.
"The Relationship of Microorganism Classification by US Government Guidelines to the Design of Laboratory Facilities"
by Dr. David Robinson, Chief Biologist, Battelle Memorial Institute.
When the first edition of the Biosafety in Microbiological and Biomedical Laboratories, (BMBL) series was published approximately 40 years ago its purpose was to provide a code of practice, guidelines and standards for the prevention of laboratory acquired infections to the laboratorian working in an infectious disease laboratory. The BMBL is based on the microorganism being worked on and is a set of recommendations which are advisory. While this is true, many agencies in the US government have incorporated all or parts of the BMBL in their regulations. This has led to the BMBL being accepted as as the de facto US standard for the design and operation of infectious disease laboratories.
ASA requested Dr. Joe Dudley, Chief Scientist for Biosecurity & Biosurveillance, EAI Corporation, a subsidiary of SAIC, to review and provide an executive summary report on the following exceptionally important notice from the US Department of Health and Human Services (DHHS). This Program's acronym is PHEMCE
The Public Health Emergency Medical Countermeasures Enterprise Strategy for Chemical, Biological, Radiological and Nuclear Threats
Joseph P. Dudley PhD
This notice was issued 15 March 2007 by the Office of the Assistant Secretary for Preparedness and Response, DHHS, and published 20 March 2007 in Federal Register Volume 72, Number 53: 13109 - 13114. It is available at: http://frwebgate.access.gpo.gov/cgi-bingetdoc.cgi?dbname= 2007_register&docid =%5b DOCID:fr20mr07-65.
an inside look at ASA 07-2
This is the CBMTS Industry V
"Fourth World Congress CBR & Terrorism"